AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2021
Sep 10, 2021
33298_dirs_2021-09-10_aaae6fef-38b4-4390-8daf-93c030f3da77.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2021-06-10
Reporting Person: Mironov Alexander (President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-10 | Stock Option (Right to Buy) | $14.04 | A | 200000 | Acquired | 2026-06-09 | Common Stock (200000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2857 | Direct |
Footnotes
F1: 1/36th of the shares vest on the date of grant. Subject to the terms of the Option Agreement and subject to the Reporting Person continuing to perform services for the Company on each vesting date, the remaining 35/36th of the shares shall vest ratably and become exercisable in equal monthly tranches on the 11th day of each calendar month, over 35 consecutive months, commencing on July 11, 2021.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17